Ads
related to: does peripheral neuropathy ever go away after a stroke patient gets
Search results
Results From The WOW.Com Content Network
Peripheral neuropathy is a general term that indicates any disorder of the peripheral nervous system. [2] The name of the disorder itself can be broken down in order to understand this better; peripheral: in regard to peripheral neuropathy, refers to outside of the brain and spinal cord; neuro: means nerve related; -pathy; means disease. [1]
Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).
The incidence of post-stroke depression peaks at 3–6 months and usually resolves within 1–2 years after the stroke, although a minority of patients can go on to develop chronic depression. The diagnosis of post-stroke depression is complicated by other consequences of stroke such as fatigue and psychomotor retardation – which do not ...
Damage to the peripheral nervous system or central nervous system can result in a decline or loss of pallesthesia. A diminished sense of vibration is known as pallhypesthesia. [3] To determine whether a patient has diminished or absent pallesthesia, testing can be conducted using a tuning fork at 128 Hz by placing it on the skin overlying a ...
Vasculitic neuropathy is a peripheral neuropathic disease. [ 1 ] [ 2 ] [ 3 ] In a vasculitic neuropathy there is damage to the vessels that supply blood to the nerves . [ 1 ] [ 2 ] [ 3 ] It can be as part of a systemic problem or can exist as a single-organ issue only affecting the peripheral nervous system (PNS).
Additionally, BP control in those with diabetes is helpful, while intravenous immunoglobulin is used for multifocal motor neuropathy. [ 1 ] According to Lopate, et al., methylprednisolone is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin).